These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19188882)

  • 1. [Cytokines as markers of osteolysis in the diagnostics of patients with bone metastases].
    Groblewska M; Mroczko B; Czygier M; Szmitkowski M
    Postepy Hig Med Dosw (Online); 2008 Dec; 62():668-75. PubMed ID: 19188882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.
    Adler HL; McCurdy MA; Kattan MW; Timme TL; Scardino PT; Thompson TC
    J Urol; 1999 Jan; 161(1):182-7. PubMed ID: 10037394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
    Chirgwin JM; Guise TA
    Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical parameters of bone metabolism in bone metastases of solid tumors (review).
    Meijer WG; van der Veer E; Willemse PH
    Oncol Rep; 1998; 5(1):5-21. PubMed ID: 9458286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating sRAGE in the diagnosis of osteolytic bone metastasis.
    Galliera E; Marazzi MG; Vianello E; Drago L; Luzzati A; Bendinelli P; Maroni P; Tacchini L; Desiderio MA; Corsi Romanelli MM
    J Biol Regul Homeost Agents; 2016; 30(4):1203-1208. PubMed ID: 28078875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
    van der Pluijm G; Sijmons B; Vloedgraven H; Deckers M; Papapoulos S; Löwik C
    J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteolytic and osteoblastic bone metastases: two extremes of the same spectrum?
    Ortiz A; Lin SH
    Recent Results Cancer Res; 2012; 192():225-33. PubMed ID: 22307378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
    Guise TA; Chirgwin JM
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor.
    Morgan H; Tumber A; Hill PA
    Int J Cancer; 2004 May; 109(5):653-60. PubMed ID: 14999770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone resorption activity of osteolytic metastatic lung and breast cancers.
    Shih LY; Shih HN; Chen TH
    J Orthop Res; 2004 Nov; 22(6):1161-7. PubMed ID: 15475192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-bone cellular interactions in skeletal metastases.
    Chirgwin JM; Mohammad KS; Guise TA
    J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):308-18. PubMed ID: 15615499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
    Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
    Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-18 inhibits osteolytic bone metastasis by human lung cancer cells possibly through suppression of osteoclastic bone-resorption in nude mice.
    Iwasaki T; Yamashita K; Tsujimura T; Kashiwamura S; Tsutsui H; Kaisho T; Sugihara A; Yamada N; Mukai M; Yoneda T; Okamura H; Akedo H; Terada N
    J Immunother; 2002; 25 Suppl 1():S52-60. PubMed ID: 12048351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in patients with neuroblastoma.
    Granchi D; Garaventa A; Amato I; Paolucci P; Baldini N
    Int J Cancer; 2006 Jul; 119(1):146-51. PubMed ID: 16450378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of osteolytic bone metastases in breast carcinoma.
    Käkönen SM; Mundy GR
    Cancer; 2003 Feb; 97(3 Suppl):834-9. PubMed ID: 12548583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
    Francini G; Gonnelli S; Petrioli R; Bruni S; Marsili S; Aquino A; Camporeale A
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):125-9. PubMed ID: 8467247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of bone metastasis formation].
    Peyruchaud O
    J Soc Biol; 2007; 201(3):229-36. PubMed ID: 18157074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future treatment of bone metastases.
    Lipton A
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6305s-6308s. PubMed ID: 17062719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer metastasis to bone: it is not all about PTHrP.
    Bendre M; Gaddy D; Nicholas RW; Suva LJ
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S39-45. PubMed ID: 14600591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.